CLINICAL_TRIALS
trial_result
· 2021-05-03
Clinical Trial Update: Hepatitis B Birth Dose for Newborns [Phase 4]
Summary
A Phase 4 clinical trial update on administering a Hepatitis B birth dose to newborns has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Quaid-e-Azam University | Conditions: Hepatitis B, Immunization; Infection | Phase 4 | Status: COMPLETED